FDA issues new labeling for gadolinium contrast
The U.S. Food and Drug Administration (FDA) in April published revised product...Read more on AuntMinnie.comRelated Reading:
Japan adopts new gadolinium use restrictions
Safety issues linger over gadolinium-based contrast agents
Norris lawsuit puts personal face on gadolinium debate
Evidence mounts: Use macrocyclic GBCAs in pediatric MRI
FDA panel votes to add retention warning to GBCA labels
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Food and Drug Administration (FDA) | Japan Health | Lawsuits | Legislation | Pediatrics | Warnings